Saptalis Pharmaceuticals LLC
Saptalis Pharmaceuticals LLC is a privately held, Hauppauge-based pharmaceutical firm founded in 2015 that manufactures, develops, and commercializes pharmaceutical products. The company operates at a small scale with 11-50 employees focused on specialty pharma activities.
- Company typePrivate
- Founded2015
- HeadquartersHauppauge, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Saptalis Pharmaceuticals LLC does
Saptalis Pharmaceuticals LLC is a privately held, for-profit pharmaceutical company founded in 2015 and headquartered in Hauppauge, United States. Per its firmographic profile, the company's stated business is the manufacturing, development, and commercialization of pharmaceutical products, positioning it across the specialty/generic pharma value chain from formulation through commercial distribution. The firm operates at a small scale, with a reported headcount of 11-50 employees, suggesting a focused portfolio rather than broad-spectrum big-pharma operations.
The company's operating model centers on three integrated functions: product development, manufacturing, and commercialization. This vertical integration implies Saptalis is engaged in bringing pharmaceutical products from formulation through regulatory compliance into market distribution, though no specific products, therapeutic categories, or pipeline assets are disclosed in the available data. The firm's product portfolio, regulatory filings, distribution channels, and customer relationships are not described in the input material, and the company's own website domain currently displays only a security verification page with no substantive content, limiting direct first-party insight.
No management team detail is disclosed beyond a single named executive serving as Vice President of Commercial Operations. The company does not appear to have a parent entity, public listing, app presence, API platform, or known subsidiary structure. No funding rounds, M&A activity, partnerships, patents, certifications, or customer logos are documented in the available data, leaving the commercial footprint and capital structure effectively opaque from public sources at this time.
Saptalis Pharmaceuticals LLC firmographics
Firmographics- Name
- Saptalis Pharmaceuticals LLC
- Legal name
- Saptalis Pharmaceuticals LLC
- Website
- https://saptalis.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Saptalis Pharmaceuticals LLC is a privately held, Hauppauge-based pharmaceutical firm founded in 2015 that manufactures, develops, and commercializes pharmaceutical products. The company operates at a small scale with 11-50 employees focused on specialty pharma activities.
- Ownership category
- akta.pro rank
Saptalis Pharmaceuticals LLC industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)
Keywords
Where Saptalis Pharmaceuticals LLC is headquartered
LocationHeadquarters
- HQ city
- Hauppauge
- HQ country
- United States
- HQ region
- North America
Markets served
Saptalis Pharmaceuticals LLC business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Saptalis Pharmaceuticals LLC product offering
Product offeringCore offering
Saptalis Pharmaceuticals LLC is a pharmaceutical product manufacturing, development, and commercialization company. The company focuses on producing and bringing to market pharmaceutical products for the U.S. healthcare system, operating from its base in Hauppauge, United States, since its founding in 2015.
Differentiator
Problem solved
Functional benefit
Companies that use Saptalis Pharmaceuticals LLC
Customer profileIdeal customer profiles1 record
Saptalis Pharmaceuticals LLC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Saptalis Pharmaceuticals LLC partnerships and signals
Strategic signalRecent moves1 record
Saptalis Pharmaceuticals LLC competitors and assessment
Company assessmentBroad incumbents
- Aurobindo Pharma: Vertically integrated Indian global generic pharmaceutical manufacturer with significant U.S. generic business — directly competes on the same molecules and channels that a U.S.-based generic manufacturer like Saptalis supplies.
- Zydus Pharmaceuticals (USA): U.S. arm of Zydus Cadila, focused on finished generic formulations sold into the U.S. market — directly comparable to Saptalis on generic product development and U.S. commercialization.
- Glenmark Pharmaceuticals: India-headquartered generics manufacturer with a U.S. commercial arm selling finished generic formulations — comparable in end markets and product categories to Saptalis, though at materially larger scale.
- Hikma Pharmaceuticals: U.S./MENA-headquartered specialty generics manufacturer with a strong injectable franchise — competes head-to-head with U.S. generic manufacturers on injectable and specialty generic SKUs.
- Baxter International: Large global manufacturer with a U.S. injectables and sterile manufacturing franchise — overlaps with Saptalis in injectable/semi-solid dosage forms and competes for the same hospital and channel customers.
- Apotex: Large Canadian-headquartered generic pharmaceutical manufacturer with a U.S. commercial footprint supplying a broad range of generic finished dosage forms — operates at greater scale but in the same generic manufacturing and commercialization category.
- Endo International: Diversified specialty and generics pharmaceutical company (including through its Par and Sterling subsidiaries) with a meaningful small-molecule generic and injectable portfolio overlapping Saptalis's likely product mix.
Direct peers
- Alvogen: Privately held specialty generics pharmaceutical company developing and commercializing generics including injectables and semi-solids — closely comparable on product mix, channel, and private-company structure.
- Amneal Pharmaceuticals: Generic and specialty pharmaceutical developer/manufacturer with a strong franchise in injectables and complex generics — highly comparable to Saptalis on dosage-form focus and integrated development-to-commercialization model.
- Lannett Company: U.S.-focused small/mid-cap generic pharmaceutical manufacturer developing, producing, and commercializing finished generic dosage forms — directly comparable to Saptalis on product category, scale, and channel.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Saptalis Pharmaceuticals LLC social profiles
Digital presenceSaptalis Pharmaceuticals LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Saptalis Pharmaceuticals LLC leadership team
Management profileNumber of profiles
Profiles1 record
Saptalis Pharmaceuticals LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Saptalis Pharmaceuticals LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Saptalis Pharmaceuticals LLC
What does Saptalis Pharmaceuticals LLC do?
Saptalis Pharmaceuticals LLC is a pharmaceutical product manufacturing, development, and commercialization company. The company focuses on producing and bringing to market pharmaceutical products for the U.S. healthcare system, operating from its base in Hauppauge, United States, since its founding in 2015.
Is Saptalis Pharmaceuticals LLC a public or private company?
Saptalis Pharmaceuticals LLC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Saptalis Pharmaceuticals LLC founded?
Saptalis Pharmaceuticals LLC was founded in 2015. It employs 11 to 50 people.
Where is Saptalis Pharmaceuticals LLC based?
Saptalis Pharmaceuticals LLC is headquartered in Hauppauge, United States, in the North America region.
Who are Saptalis Pharmaceuticals LLC's main competitors?
Broad incumbents on record are Aurobindo Pharma, Zydus Pharmaceuticals (USA), Glenmark Pharmaceuticals, Hikma Pharmaceuticals, Baxter International, Apotex and Endo International. Direct peers are Alvogen, Amneal Pharmaceuticals and Lannett Company.
Does Saptalis Pharmaceuticals LLC have an API?
No public API is recorded for Saptalis Pharmaceuticals LLC.
What industry is Saptalis Pharmaceuticals LLC in?
Saptalis Pharmaceuticals LLC's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAAAKAA, Biologic API/Drug Substance Manufacturing Services. Its NAICS code is 325412 and its SIC code is 2834.